Clinical trial
Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery
NCT05027893 is registered in ClinicalTrials.gov with University of Novi Sad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery
- Lead sponsor
- University of Novi Sad
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 7, 2019
- Completion date
- December 31, 2023
- Enrollment
- 157 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic reaction, antibiotic resistant infection, antibiotic resistant strain, antibiotic side effect, infection, bacterial, infection, laboratory, postoperative complications